The NGS panel should include all coding exons of the JAK2 and MPL genes, as rare non-canonical driver mutations can be detected in both MPN and constitutional thrombocythemia/polycythemia [13]. The gene discussed is JAK2; the disease is myeloproliferative neoplasm.